Current Opinion in Oncology

Top Research Topics at Current Opinion in Oncology?

The journal primarily tackles Internal medicine, Oncology, Cancer, Cancer research and Disease. It explores research in Internal medicine and the adjacent study of MEDLINE. Most of the works presented in the journal deals with MEDLINE but it intersects with the subject of Intensive care medicine.

While work presented in Current Opinion in Oncology provided substantial information on Oncology, it also covered topics in Carcinoma, Clinical trial and Immunotherapy. The work on Cancer addressed in the journal expands to the thematically related Bioinformatics. Current Opinion in Oncology focuses on Radiation therapy research as part of the broader topic of Surgery.

Research in Lymphoma discussed is concerned with the study of Immunology as a whole.

• Internal medicine (40.39%)
• Oncology (38.35%)
• Cancer (19.47%)

What are the most cited papers published in the journal?

• TGF-β signaling and epithelial-mesenchymal transition in cancer progression. (541 citations)
• Histone deacetylase inhibitors as new cancer drugs. (512 citations)
• Oncogenic PI3K and its role in cancer. (473 citations)

Research areas of the most cited articles at Current Opinion in Oncology:

The published articles are organized to reinforce research efforts on Internal medicine, Cancer research, Oncology, Cancer and Immunology. The published papers tackle studies in MEDLINE and the interrelated subject of Bioinformatics to gain insights into Internal medicine. While Oncology is the focus of the journal papers, it also provides insights into the studies of Malignancy, Clinical trial, Carcinoma, Melanoma and Breast cancer.

What topics the last edition of the journal is best known for?

• Cancer
• Internal medicine
• Disease

The previous edition focused in particular on these issues:

Current Opinion in Oncology is organized to address concerns in the fields of Internal medicine, Oncology, Clinical trial, Cancer and MEDLINE. The study of Oncology encompasses disciplines such as Adverse effect, as well as fields such as Thyroid cancer, all of which overlap with one another. In addition to Clinical trial research, the journal aims to explore topics under Non small cell and Clear cell.

While Current Opinion in Oncology focused on Cancer, it was also able to explore topics like Precision medicine, Cancer research and DNA sequencing. The Cancer research research presented in it explores the relationship between Immune system and the closely related topic of Antigen. Current Opinion in Oncology holds forums on MEDLINE that merges themes from other disciplines such as Randomized controlled trial, Immune checkpoint inhibitors, Head and neck, Intensive care medicine and Breast cancer.

The most cited articles from the last journal are:

• Triplet combination of BRAF, MEK and PD-1/PD-L1 blockade in melanoma: the more the better? (5 citations)
• MEK inhibitors in RASopathies. (4 citations)
• Malignant pleural mesothelioma: recent developments. (4 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

Top authors and change over time

The top authors publishing in Current Opinion in Oncology (based on the number of publications) are:

• Ahmad Awada (34 papers) published 1 paper at the last edition the same number as at the previous edition,
• Jean Klastersky (25 papers) absent at the last edition,
• Alain Hendlisz (20 papers) published 2 papers at the last edition, 1 more than at the previous edition,
• Cesare Gridelli (16 papers) absent at the last edition,
• Pierre Hainaut (16 papers) published 2 papers at the last edition, 1 more than at the previous edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Top affiliations and change over time

Only papers with recognized affiliations are considered

The top affiliations publishing in Current Opinion in Oncology (based on the number of publications) are:

• University of Texas MD Anderson Cancer Center (106 papers) published 2 papers at the last edition, 1 more than at the previous edition,
• Johns Hopkins University (95 papers) absent at the last edition,
• Memorial Sloan Kettering Cancer Center (76 papers) published 3 papers at the last edition, 2 more than at the previous edition,
• Université libre de Bruxelles (73 papers) published 10 papers at the last edition, 5 more than at the previous edition,
• Harvard University (61 papers) published 1 paper at the last edition, 2 less than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 12.62% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 20.00% were posted by at least one author from the top 10 institutions publishing in the journal. Another 22.22% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 13.33% of all publications and 44.44% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

• Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
• Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
• Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
• Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
• Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Career Opportunities and Further Studies in Oncology

If you're captivated by the research in this field and considering a career in oncology, it's important to equip yourself with proper education and training. In most cases, this begins with a bachelor's degree in nursing or a related field. Many individuals then further their studies by attending one of the top 10 best nursing schools in Florida or other reputable institutions across the country.

By obtaining a specialized degree and completing your practical requirements, you will be well-prepared to contribute to critical oncology research like what is found in Current Opinion in Oncology. And not just that, you will also have the opportunity to directly impact patients' lives through your work in the healthcare sector.

Whether your interests lie in clinical trials, cancer research, or radiation therapy, a strong educational foundation will pave the way for a rewarding and impactful career in oncology.

So as you explore the research topics presented in Current Opinion in Oncology, remember that beyond the pages of this journal lies a wide world of opportunities to apply this knowledge and make a real difference in the fight against cancer.